tiprankstipranks
Creightons PLC (GB:PAM)
LSE:PAM
Want to see GB:PAM full AI Analyst Report?

Creightons (PAM) AI Stock Analysis

3 Followers

Top Page

GB:PAM

Creightons

(LSE:PAM)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
26.00 p
▼(-8.77% Downside)
Action:Reiterated
Date:11/25/25
Creightons' strong financial performance and attractive valuation are the primary drivers of its overall score. The robust balance sheet and low P/E ratio suggest financial stability and potential undervaluation. However, technical indicators show a bearish trend, and the decline in free cash flow growth is a risk that needs addressing.
Positive Factors
Balance sheet strength
Creightons' very low leverage and a ROE around 10% provide durable financial flexibility. This capital structure supports investment, weathering demand shocks, and strategic optionality such as targeted M&A or capacity investment without forcing high external financing costs.
Negative Factors
Sharp decline in free cash flow growth
A near-60% drop in free cash flow growth materially reduces internal funding for capex, dividends and deleveraging. Over the medium term this constrains strategic flexibility and may increase reliance on external financing if cash conversion does not recover.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance sheet strength
Creightons' very low leverage and a ROE around 10% provide durable financial flexibility. This capital structure supports investment, weathering demand shocks, and strategic optionality such as targeted M&A or capacity investment without forcing high external financing costs.
Read all positive factors

Creightons (PAM) vs. iShares MSCI United Kingdom ETF (EWC)

Creightons Business Overview & Revenue Model

Company Description
Creightons Plc, together with its subsidiaries, develops, manufactures, and markets toiletries and fragrances in the United Kingdom and internationally. It offers haircare, skincare, bath and body, wellbeing, and male grooming products. The compan...
How the Company Makes Money
Creightons makes money primarily by selling personal care and beauty products through two main routes: (1) manufacturing and supplying products for other brand owners/retailers (often referred to as contract manufacturing or private label), where ...

Creightons Financial Statement Overview

Summary
Creightons shows strong financial performance with improving revenue and profitability margins. The balance sheet is robust with low leverage, enhancing financial stability. However, the significant decline in free cash flow growth is a concern and needs attention.
Income Statement
75
Positive
Balance Sheet
80
Positive
Cash Flow
65
Positive
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Creightons Technical Analysis

Technical Analysis Sentiment
Positive
Last Price28.50
Price Trends
50DMA
23.54
Positive
100DMA
24.28
Positive
200DMA
26.53
Negative
Market Momentum
MACD
0.33
Negative
RSI
60.61
Neutral
STOCH
55.15
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:PAM, the sentiment is Positive. The current price of 28.5 is above the 20-day moving average (MA) of 23.68, above the 50-day MA of 23.54, and above the 200-day MA of 26.53, indicating a neutral trend. The MACD of 0.33 indicates Negative momentum. The RSI at 60.61 is Neutral, neither overbought nor oversold. The STOCH value of 55.15 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:PAM.

Creightons Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
£16.45M6.359.67%3.17%-0.40%-15.64%
66
Neutral
£267.94M9.5030.98%2.12%-0.84%-25.31%
65
Neutral
£151.88M10.5118.66%5.97%3.42%-24.29%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
60
Neutral
£80.68M15.717.82%
54
Neutral
£438.79M-87.12-2.16%4.82%6.74%26.11%
42
Neutral
£43.49M-0.6497.34%-31.02%-4458.82%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:PAM
Creightons
24.50
-17.91
-42.23%
GB:MCB
McBride
164.40
16.46
11.13%
GB:PZC
PZ Cussons
102.80
32.93
47.14%
GB:VLG
Venture Life
68.50
10.75
18.61%
GB:W7L
Warpaint London
186.20
-213.98
-53.47%
GB:REVB
Revolution Beauty Group plc
5.00
0.00
0.00%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 25, 2025